Countdown to close
$
3.29
Change
-0.06 -1.79%
Volume
Volume 435,357
May 24, 2022, 3:28 p.m.
Real time quotes
Previous close
$ 3.35
$ 3.29
Change
-0.06 -1.79%
Day low
Day high
$3.14
$3.32

52 week low
52 week high
$3.08
$6.21

Market cap
$1.01B
Average volume
775,087
P/E ratio
324.02
Rev. per Employee
$299,742
EPS
0.01
Dividend
N/A
Div yield
N/A
Ex dividend date
N/A
MarketWatch News on AMRX
-
Demand Spikes for a Drug Studied as Covid-19 Cure
- Barron's Online
-
Amneal Pharma price target raised to $6 vs. $4 at SunTrust Robinson Humphrey
- Ciara Linnane
-
Federal Prosecutors Launch Criminal Probe of Opioid Makers, Distributors
- Barron's Online
-
AmerisourceBergen shares slide 2.4%; J&J down 0.7%
- Ciara Linnane
-
Amneal Pharma stock slides 9.3% and Mallinckrodt shares down 1.7%
- Ciara Linnane
-
McKesson shares slide 3.45, Teva down 8.2%
- Ciara Linnane
-
Brooklyn Federal prosecutors open criminal probe of opioid makers and distributors: WSJ
- Ciara Linnane
-
Teva, McKesson, Mallinckrodt, AmerisourceBergen, J&J and Amneal subpoenaed in probe: WSJ
- Ciara Linnane
-
Amneal Pharmaceuticals downgraded to underweight from neutral at J.P. Morgan
- Tomi Kilgore
-
Generic-Drug Stocks Are Up Today, but It’s Not a Sign of Strength
- Barron's Online
- Loading more headlines...
Analyst Ratings
-
Benzinga's Top Upgrades, Downgrades For March 7, 2018
- Benzinga.com
-
Benzinga's Top Upgrades, Downgrades For July 31, 2017
- Benzinga.com
-
Benzinga's Top Upgrades, Downgrades For July 18, 2017
- Benzinga.com
Other News on AMRX
-
10-Q: AMNEAL PHARMACEUTICALS, INC.
- Edgar Online - (EDG = 10Q, 10K)
-
Amneal falls 12% on disappointing Q1 result
- Seeking Alpha
-
Notable earnings before Wednesday's open
- Seeking Alpha
-
Amneal Pharmaceuticals Q1 2022 Earnings Preview
- Seeking Alpha
-
Over 30 generic manufacturers agree to make Pfizer COVID-19 pill
- Seeking Alpha
-
10-K: AMNEAL PHARMACEUTICALS, INC.
- Edgar Online - (EDG = 10Q, 10K)
-
Amneal Pharmaceuticals Q4 2021 Earnings Preview
- Seeking Alpha
-
Amneal gets FDA nod for 4 generic injectables products
- Seeking Alpha
- Loading more headlines...
Press Releases on AMRX
-
Amneal to Participate at the 2022 Jefferies Healthcare Conference
- BusinessWire - BZX
-
Amneal to Participate at Upcoming Investor Conferences in May
- BusinessWire - BZX
-
Amneal Reports First Quarter 2022 Financial Results
- BusinessWire - BZX
-
Norepinephrine Drug Market Size, Demand Growth, Trends & Forecast 2028
- AmericaNewsHour
-
Amneal Achieves Second U.S. Biosimilars Approval with ALYMSYS® (bevacizumab-maly)
- BusinessWire - BZX
-
Amneal to Report First Quarter 2022 Results on May 4, 2022
- BusinessWire - BZX
- Loading more headlines...
Rates »
National averages from Bankrate.com
National averages from Bankrate.com
National averages from Bankrate.com